A screen now identifies a protein that regulates degradation of mutant huntingtin, which causes Huntington's disease, and manipulations show that promoting clearance of the toxic protein itself may be sufficient to halt disease.
References
Lu, B. et al. Nat. Neurosci. 16, 562–570 (2013).
Yamamoto, A., Lucas, J.J. & Hen, R. Cell 101, 57–66 (2000).
Kordasiewicz, H.B. et al. Neuron 74, 1031–1044 (2012).
Weiss, A. et al. Anal. Biochem. 395, 8–15 (2009).
Mitra, S., Tsvetkov, A.S. & Finkbeiner, S. Autophagy 5, 1037–1038 (2009).
Dragatsis, I., Levine, M.S.M. & Zeitlin, S.S. Nat. Genet. 26, 300–306 (2000).
Kaltenbach, L.S. et al. PLoS Genet. 3, e82 (2007).
Liu, G. & Xirodimas, D.P. Oncogene 29, 2252–2261 (2010).
Bae, B.-I. et al. Neuron 47, 29–41 (2005).
Kito, K. J. Biol. Chem. 276, 20603–20609 (2001).
Bouchard, J. et al. J. Neurosci. 32, 18259–18268 (2012).
Seifert, U. et al. Cell 142, 613–624 (2010).
Díaz-Hernández, M. et al. J. Neurosci. 23, 11653–11661 (2003).
Richet, E. et al. Hum. Mol. Genet. 21, 5254–5267 (2012).
Tanji, K. et al. Am. J. Pathol. 169, 553–565 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Aron, R., Tsvetkov, A. & Finkbeiner, S. NUB1 snubs huntingtin toxicity. Nat Neurosci 16, 523–525 (2013). https://doi.org/10.1038/nn.3380
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3380
- Springer Nature America, Inc.
This article is cited by
-
Quality Control in Huntington’s Disease: a Therapeutic Target
Neurotoxicity Research (2019)